Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: Similarities and differences

European Heart Journal

Volumn 35, Issue 3, 2014, Pages 147-155

  Widimsky, Petr ^a   Coram, Rita ^b   Abou Chebl, Alex ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b University of Louisville School of Medicine   (United States)

Author keywords

Acute stroke; Catheter intervention; Myocardial infarction; Primary angioplasty; Reperfusion; Thrombectomy; Thrombolysis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; PLACEBO;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION PREVENTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CARDIOVASCULAR MORTALITY; CAROTID ARTERIOGRAPHY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CORONARY ARTERY OCCLUSION; CORONARY STENT; DIAGNOSTIC PROCEDURE; DISABILITY; EMBOLECTOMY SYSTEM; FIBRINOLYTIC THERAPY; HEART INFARCTION PREVENTION; HUMAN; LABORATORY DIAGNOSIS; META ANALYSIS (TOPIC); MIDDLE CEREBRAL ARTERY OCCLUSION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT RETRIEVER; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION;

ACUTE STROKE; CATHETER INTERVENTION; MYOCARDIAL INFARCTION; PRIMARY ANGIOPLASTY; REPERFUSION; THROMBECTOMY; THROMBOLYSIS;

ACUTE DISEASE; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY;

EID: 84892703056     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht409     Document Type: Article

References (52)

1. Chazov EI, Matveeva LS, Mazaev AV, Sargin KE, Sadovskaia GV, Ruda MI. Intracoron-ary administration of fibrinolysin in acute myocardial infarct. Ter Arkh 1976;48:8-19.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
4. Meyer J, Merx W, Schweizer P, Dörr R, Lambertz H, Bethge C, Erbel R, Effert S. Selective intracoronary lysis and transluminal coronary dilation as an immediate measure in acute myocardial infarct. Verh Dtsch Ges Herz Kreislaufforsch 1982;48: 157-165.
5. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL Jr, McCallister BD, Gura GM Jr, Conn RC, Crockett JE. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106(5 Pt 1):965-973.
6. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A compari-sonofimmediate coronaryangioplasty with intravenous streptokinaseinacute myo-cardial infarction. N Engl J Med 1993;328:680-684.
7. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-679.
8. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993;328: 685-691.
9. Widimsky P, Janousek S, Vojácek J. Czech Society of Cardiology guidelines for the diagnosis and treatment of acute myocardial infarction (Q-wave/ST elevations/bundle branch block). Cor Vasa 2002;44:K123-K143.
10. Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, Hardin WB, Landau WM, Raichle ME. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976;7:135-142.
11. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-982.
12. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
13. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ, Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke:ascientific statement fromthe Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
14. Bellon RJ, Putman CM, Budzik RF, Pergolizzi RS, Reinking GF, Norbash AM. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ische-mic stroke. Am J Neuroradiol 2001;22:526-530.
15. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Guidelines for the early management of patients with acute is-chemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
16. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasmino-gen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5years. Stroke 2011;42:1952-1955.
17. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U, European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010;31:943-957.
18. Kristensen SD, Fajadet J, Di Mario C, Kaifoszova Z, Laut KG, Deleanu D, Gilard M, Guagliumi G, Goktekin O, Jorgova J, Kanakakis J, Ostojic M, Pereira H, Sabate M, Sobhy M, Vrints C, Wijns W, Widimsky P. Implementation of primary angioplasty in Europe: stent for life initiative progress report. Euro Intervention 2012;8:35-42.
19. Ahmed S, Antman EM, Murphy SA, Giugliano RP, Cannon CP, White H, Morrow DA, Braunwald E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis 2006;21:119-129.
20. Hacke W, Kaste M, Bluhmki E, Brozman M, DávalosA, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase3to4. 5 hours after acute ischemicstroke. N Engl J Med 2008;359:1317-1329.
21. IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379:2352-2363.
22. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009:CD000213. doi: 10.1002/14651858.CD000213.pub2.
23. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-1703.
24. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309: 1477-1482.
25. Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, Horowitz S, Goldman M, Karsch K, Meilman H. Effects of intracoronaryst reptokinase and intracoronary nitro-glycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med 1984;311:1457-1463.
26. Simoons ML, Serruys PW, vd Brand M, Bär F, de Zwaan C, Res J, Verheugt FW, Krauss XH, Remme WJ, Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet 1985;2:578-582.
27. Patel B, Kloner RA. Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. Am J Cardiol 1987;59:501-504.
28. Widimský P, Groch L, Zelízko M, Aschermann M, Bednár F, Suryapranata H. Multi-centre randomized trial comparing transport to primary angioplasty vs immediate thrombolysisvscombined strategy for patients with acute myocardial infarction presenting to acommunity hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-831.
29. Mazighi M, Meseguer E, Labreuche J, Amarenco P. Bridging therapyin acute ischemic stroke. A systematic review and meta-analysis. Stroke 2012;43:1302-1308.
30. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ische-mic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
31. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T, MELT Japan Study Group. Randomized trial of intraarterial infu-sionofurokinase within 6hoursofmiddle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38: 2633-2639.
32. Kharitonova T, Ahmed N, Thoren M, Wardlaw JM, von Kummer R, Glahn J, Wahlgren N. Hyperdensemiddle cerebral artery sign on admission CT scan-prognostic significance for ischaemic stroke patients treated with intravenous thromb-olysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009;27:51-59.
33. De Silva DA, Brekenfeld C, Ebinger M, Christensen S, Barber PA, Butcher KS, Levi CR, Parsons MW, Bladin CF, Donnan GA, Davis SM. The benefitsofintravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010;41:295-299.
34. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-1777.
35. Saver JL, Yafeh B. Confirmation of tPA treatment effect bybaseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. Stroke 2007;38:414-416.
36. Vermeer F, Oude Ophuis AJ, vdBerg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bär FW. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocar-dial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999;82:426-431.
37. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction-phase 5 randomized trial. TAMI Study Group. Circulation 1991;83:1543-1556.
38. ASS, ENT-4 Investigators. Primary versustenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367: 569-578.
39. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013;368: 1379-1387.
40. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903.
41. Widimský P, Budesínský T, Vorác D, Groch L, Zelízko M, Aschermann M, Branny M, St'ásek J, Formánek P;'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104.
42. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS, DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742.
43. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombo-lytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
44. White CJ, Abou-Chebl A, Cates CU, Levy EI, McMullan PW, Rocha-Singh K, Weinberger JM, Wholey MH. Stroke intervention: catheter-based therapy for acute ischemic stroke. J Am Coll Cardiol 2011;58:101-116.
45. The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectivenessof anew generation ofmechanical devicesfor clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-2768.
46. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO, SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-1249.
47. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-1240.
48. Dorn F, Stehle S, Lockau H, Zimmer C, Liebig T. Endovascular treatment of acute intracerebral artery occlusions with the Solitaire stent: single-centre experience with 108 recanalization procedures. Cerebrovasc Dis 2012;34:70-77.
49. Jovin TG, Liebeskind DS, Gupta R, Rymer M, Rai A, Zaidat OO, Abou-Chebl A, Baxter B, Levy EI, Barreto A, Nogueira RG. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42:2206-2211.
50. Almekhlafi MA, Menon BK, Freiheit EA, Demchuk AM, Goyal M. A meta-analysis of observational intra-arterial stroke therapy studies using the Merci device, Penumbra system, and retrievable stents. AJNR Am J Neuroradiol 2012. Published online ahead of print 26 July.
51. Abou-Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Tayal AH, Zaidat OO, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Kalia JS, Nguyen TN, Chen M, Gupta R. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010; 41:1175-1179.
52. Papanagiotou P, Roth C, Walter S, Behnke S, Grunwald IQ, Viera J, Politi M, Körner H, Kostopoulos P, Haass A, Fassbender K, Reith W. Carotid artery stenting in acute stroke. J Am Coll Cardiol 2011;58:2363-2369.